Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_assertion type Assertion NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_head.
- NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_assertion description "[In addition, both BA treatment and mithramycin A (MMA) treatment inhibited lung tumor growth and down-regulated Sp1 protein expression in Kras(G12D)-induced lung cancers of bitransgenic mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_provenance.
- NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_assertion evidence source_evidence_literature NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_provenance.
- NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_assertion SIO_000772 22956772 NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_provenance.
- NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_assertion wasDerivedFrom befree-20140225 NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_provenance.
- NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_assertion wasGeneratedBy ECO_0000203 NP304553.RAg3277_Esh3sUi-QbMI0xUShr1QTESwGUaUBLQ9q1cvU130_provenance.